Featured Research

Everolimus Shows Benefit Against SEGA Tumors While there is no “magic bullet” for tuberous sclerosis complex (TSC), researchers have demonstrated the power of everolimus to treat acute symptoms and, more significantly, reverse the effects of a genetic defect associated with the disease.

Read Featured Research

Division Summary

Research and Training Details

Joint Appointment Faculty1
Research Fellows and Post Docs1
Research Graduate Students5
Total Annual Grant Award Dollars$1,522,316
Total Annual Industry Award Dollars$1,085,089

Clinical Activities and Training

Staff Physicians1
Clinical Fellows5
Inpatient Encounters6,970
Outpatient Encounters33,193